Logo
SearchSearch
Languages
Language
LoginSign up
Login
Invest in Akebia Therapeutics Inc
Today
Create an eToro account to buy AKBA stock on a secure, user-friendly, multi-asset trading platform.
Buy Akebia Therapeutics Inc
Buy Akebia Therapeutics Inc
Akebia Therapeutics Inc AKBA
Buy AKBA
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
7.5
Based on analysts who covered AKBA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Akebia Therapeutics Inc News

Stocks-AKBA-Akebia Therapeutics Inc

Akebia Therapeutics Inc AKBA

$2.230.57(34.34%)(1D)
• Nasdaq • in USD

AKBA Stock Price Chart

‎5.69‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Akebia Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Akebia Therapeutics Inc share price today is $2.23, reflecting a ‎34.34‎% change over the last 24 hours and ‎19.25‎% over the past week. The current market capitalization of AKBA is 368.73M with an average volume in the last three months of 2.38M. The stock has a P/E ratio of -7.66 and a dividend yield of 0%. With the stock’s beta sitting at 1.71
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$368.73M
Day’s Range
i
Shows the high and low prices of the day.
1.5 - 2.23
52W Range
i
Shows the high and low prices of the last year.
0.78 - 2.43
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.38M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-7.66
Revenue
i
The total income generated by this company’s goods and services last year.
$169.88M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
$1.69
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.22
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.71
What Is Akebia Therapeutics Inc?
Operating internationally, Akebia Therapeutics is a fully integrated biopharmaceutical company. It works to develop and commercialise medications for the treatment of complications related to kidney disease. As of November 2020, the company has one commercially available medicine available within the US (Auryxia) and another medicine in global phase III development (Vadadustat). Founded in 2007, the company has its headquarters in Cambridge, Massachusetts.

The company's stock is available on the NASDAQ GS stock market using the AKBA ticker. In November 2020, this stock was trading at $3.39. The AKBA share price ranged from a 52-week high of $13.71 in both April 2020 and June 2020 before dropping to a 52-week low of $2.09 in September 2020. As of November 2020, this stock provided a -36.28% one-year return.

Akebia Therapeutics' lead product candidate, Vadudustat, is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI). The drug is intended to be used to treat anaemia due to chronic kidney disease. This candidate is in phase III clinical development. It has been approved for use within Japan for adult patients, including both dialysis-dependent and non-dialysis dependent patients.

For more information on AKBA stock and to keep up with the latest developments, make it an entry on your eToro watchlist.
Buy AKBA

How can I buy Akebia Therapeutics Inc stocks?

To purchase Akebia Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Akebia Therapeutics Inc (AKBA) page and place an order to buy Akebia Therapeutics Inc.
Buy AKBA
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Akebia Therapeutics Inc
Invest in Akebia Therapeutics Inc
Today
Create an eToro account to buy AKBA stock on a secure, user-friendly, multi-asset trading platform.
Buy AKBA

FAQ

The current price of AKBA is $2.23.
The average price target for Akebia Therapeutics Inc is $2.23. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Akebia Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Akebia Therapeutics Inc is $368.73M
Daily Movers
Explore the biggest stocks movers on the market.
Buy AKBA
Scroll to top